Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11266654 Apilimod compositions and methods for using same

Patent 11266654 was granted and assigned to AI Therapeutics on March, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

OrphAI Therapeutics

Current Assignee

OrphAI Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

112666540

Patent Inventor Names

Tian Xu0

Paul Beckett0

Sean Landrette0

Sophia Gayle0

Chris Conrad0

Henri Lichenstein0

Jonathan M. Rothberg0

Matt Dyer0

...

Date of Patent

March 8, 2022

Patent Application Number

167285660

Date Filed

December 27, 2019

Patent Citations

‌

US Patent 10350213 Methods for treating cancer using apilimod

‌

US Patent 10179135 Apilimod compositions and methods for using same

‌

US Patent 10206910 Apilimod for use in the treatment of renal cancer

‌

US Patent 10765682 Apilimod for use in the treatment of melanoma

Patent Primary Examiner

‌

Samira J Jean-Louis

Patent abstract

The present invention relates to methods for treating cancer with apilimod and related compositions and methods.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11266654 Apilimod compositions and methods for using same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API